High Follistatin Predicts Poor Cardiometabolic Outcomes

Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.

Related Keywords

Sweden ,Swedish ,Gunnar Engstr , ,Preprints With The Lancet ,Diet Cancer Study ,Yang De Marinis ,Lundoch Diagnostics ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Renal Failure ,Enal Insufficiency ,Idney Insufficiency ,Kidney Failure ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Heart ,Heart Failure ,Plasma ,Atherosclerotic Heart Disease ,Theroscleroti ,